Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Ocata Therapeutics revenue
Ocata Therapeutics's revenue is $506,419.
What is Ocata Therapeutics's revenue?
- Ocata Therapeutics has 37 employees, and the revenue per employee ratio is $13,687.
- Ocata Therapeutics peak revenue was $506.4K in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Ocata Therapeutics financing
Ocata Therapeutics received early financing of $2.8M on 2009-11-12.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Debt | $2.8M | 11/2009 |
| Post Ipo Equity | $30M | 07/2014 |
| Post Ipo Debt | $10M | 08/2015 |
Ocata Therapeutics investors
| Investors | Security type |
|---|---|
| LINCOLN PARK CAPITAL | Post Ipo Equity |
| SVB Financial Group | Post Ipo Debt |
Ocata Therapeutics competitors
Ocata Therapeutics's top competitor, Stemline Therapeutics, earned an annual revenue of $43.2M.
Ocata Therapeutics's smallest competitor is Optherion with revenue of $610.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| BioTime | - | $3.4M | 101 | - |
| Fate Therapeutics | - | $13.6M | 104 | - |
| Leap Therapeutics | - | $1.5M | 30 | - |
| FUJIFILM Cellular Dynamics | - | $16.7M | 75 | - |
| Stemline Therapeutics | - | $43.2M | 100 | - |
| Minerva Biotechnologies | - | $2.4M | 24 | - |
| Magenta Therapeutics | - | $6.2M | 125 | - |
| Gemini Therapeutics | - | $1.6M | 36 | - |
| Intl Stem Cell | - | $7.1M | 20 | - |
| Optherion | - | $610,000 | 3 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Ocata Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Ocata Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Ocata Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Ocata Therapeutics. The data presented on this page does not represent the view of Ocata Therapeutics and its employees or that of Zippia.
Ocata Therapeutics may also be known as or be related to OCATA THERAPEUTICS, INC. and Ocata Therapeutics.